These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 17875340

  • 1. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.
    de Castro J, Belda-Iniesta C, Isla D, Dómine M, Sánchez A, Batiste E, Barón MG.
    Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340
    [Abstract] [Full Text] [Related]

  • 2. Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study.
    de Castro J, Ordóñez A, Isla D, Sánchez A, Arrivi A, Manzano JL, Barón MG.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):35-42. PubMed ID: 16874498
    [Abstract] [Full Text] [Related]

  • 3. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B, van de Werf PR, Melissant CF, Brok RG.
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P, Kritikos K, Hatzopoulos A, Mitsibounas D.
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
    [Abstract] [Full Text] [Related]

  • 7. Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.
    Granetto C, Ricci S, Martoni A, Pezzella G, Testore F, Mattioli R, Lampignano M, Tacconi F, Porrozzi S, Gasparini G, Mantovani G, EPO-ITA3 Study Group.
    Oncol Rep; 2003 Nov; 10(5):1289-96. PubMed ID: 12883695
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.
    Suzuki Y, Tokuda Y, Fujiwara Y, Minami H, Ohashi Y, Saijo N.
    Jpn J Clin Oncol; 2008 Mar; 38(3):214-21. PubMed ID: 18296425
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR.
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [Abstract] [Full Text] [Related]

  • 14. Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
    Kosmidis P, Krzakowski M, ECAS Investigators.
    Lung Cancer; 2005 Dec; 50(3):401-12. PubMed ID: 16191450
    [Abstract] [Full Text] [Related]

  • 15. Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.
    Boogaerts M, Oberhoff C, Ten Bokkel Huinink W, Nowrousian MR, Hayward CR, Burger HU.
    Anticancer Res; 2006 Dec; 26(1B):479-84. PubMed ID: 16739308
    [Abstract] [Full Text] [Related]

  • 16. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
    Littlewood TJ, Nortier J, Rapoport B, Pawlicki M, de Wasch G, Vercammen E, Schuette W, Wils J, Freund M, Epoetin Alfa Study Group.
    Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
    [Abstract] [Full Text] [Related]

  • 17. Epoetin beta (NeoRecormon) corrects anaemia in patients with hormone-refractory prostate cancer and bone metastases.
    Bogdanos J, Karamanolakis D, Milathianakis K, Repousis P, Chloraki-Bobota A, Majed H, Pagalou-Thoua E, Tsintavis A, Koutsilieris M.
    Anticancer Res; 2004 Dec; 24(3b):1957-61. PubMed ID: 15274384
    [Abstract] [Full Text] [Related]

  • 18. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G.
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin beta in peritoneal dialysis patients with chronic renal anaemia.
    Grzeszczak W, Sulowicz W, Rutkowski B, de Vecchi AF, Scanziani R, Durand PY, Bajo A, Vargemezis V, European Collaborative Group.
    Nephrol Dial Transplant; 2005 May; 20(5):936-44. PubMed ID: 15769814
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.